>> Continued From the Previous Page <<
Critics have raised eyebrows over the connection between COVID-19 vaccines and various diseases. The Defender brings to light several reports associating the COVID-19 shot with conditions such as shingles and EBV.
Highlighting the controversy, a 2021 study documented 54 cases of herpes zoster (shingles) manifesting approximately a week following COVID-19 vaccination. A subsequent study in 2022 echoed these findings, noting cases of herpes zoster reactivation within weeks after vaccination.
Hélène Banoun, Ph.D., a French scientist, has discussed the potential disorganization of the innate immune system due to vaccination, which might contribute to the reactivation of latent viruses. Banoun’s insights suggest a broader impact of vaccinations on latent diseases, including tuberculosis and even leprosy, pointing to an uptick in such ancient diseases in various countries post-vaccination.
The notion of vaccine-induced conditions extends to the realm of cancer, with Dr. Geert Vanden Bossche voicing concerns over “turbo cancers” driven by elevated IgG4 levels. Reports of rapid cancer progression in young individuals post-vaccination add weight to these apprehensions.
ALERT! Major Water Restrictions In Effect!
Banoun’s critique underscores a shift in Moderna’s focus from cancer vaccines to mRNA vaccines for infectious diseases, hinting at an unsettling trend of increasing cancer incidences potentially linked to anti-COVID vaccines.
This narrative paints a complex picture of Moderna’s vaccine development efforts. On one hand, there’s the promise of groundbreaking vaccines capable of combating a range of diseases. On the other, there are alarming reports suggesting a possible link between these vaccines and the reactivation or exacerbation of serious conditions.
The unfolding story of Moderna’s vaccine development journey is emblematic of the broader challenges facing medical innovation today. As the company continues to push the boundaries of what’s possible with mRNA technology, the global community watches closely, balancing the potential benefits against the concerns raised by critics.
